Skip to content

Menu

Sheppard, Mullin, Richter & Hampton LLP logo
HomePracticeEventsResourcesContact

Government Contracts & Investigations Blog

Latest updates on Developments Affecting Government Contracts & Investigations

MEDICARE

Subscribe to MEDICARE
Healthcare-Blog-Image-doctor-HC-icons-656x281

HHS OIG Report On Prior Authorizations Under Medicare Advantage

By Christine Clements & Arushi Pandya* on May 27, 2022
Posted in Healthcare

Last month, the U.S. Department of Health and Human Services Office of Inspector (“OIG”) released a report that studied prior authorization denials and payment denials by Medicare Advantage Organizations (“MAOs”)…

Continue Reading HHS OIG Report On Prior Authorizations Under Medicare Advantage
Healthcare-Blog-Image-doctor-icons-blocks-656x281

CMS Issues Contract Year 2023 Final Rule for Medicare Advantage Organizations and Prescription Drug Sponsors

By Xavier Baker, Christine Clements, Jarrod Brodsky & Theresa Thompson on May 27, 2022
Posted in Healthcare

On April 29, 2022, the Centers for Medicare and Medicaid Services (“CMS”), issued the final rule on Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and…

Continue Reading CMS Issues Contract Year 2023 Final Rule for Medicare Advantage Organizations and Prescription Drug Sponsors
Subscribe
Sheppard Mullin Blogs

Stay Connected

Subscribe to this blog via RSS LinkedIn Twitter Facebook

About This Blog

Sheppard Mullin’s Government Contracts Practice Group provides a full range of legal services to clients that do business with governmental entities. We advise clients on complying with complex government regulations and defending them in the event of litigation.

Topics

Archives

Recent Updates

  • Supreme Court To Review DOJ’s Authority to Dismiss Qui Tam FCA Suits Over Objections From Relators
  • Updated Timeline for CMMC Implementation
  • HHS OIG Report On Prior Authorizations Under Medicare Advantage
  • CMS Issues Contract Year 2023 Final Rule for Medicare Advantage Organizations and Prescription Drug Sponsors
  • ESG for Government Contractors: Climate-Related Risk Considerations in Federal Procurement

Sheppard Mullin Blogs

  • Antitrust Law Blog
  • Art Law Blog
  • Cannabis Law Blog
  • China Law Update Blog
  • Class Action Defense Strategy Blog
  • Construction & Infrastructure Law Blog
  • Consumer Finance and Fintech Blog
  • Corporate & Securities Law Blog
  • Covering Your Ads Blog
  • Energy Law Blog
  • Entertainment Law Blog
  • Executive Compensation Law Blog
  • Eye on Privacy Blog
  • FCC Law Blog
  • FDA Law Blog
  • Fashion & Apparel Law Blog
  • Finance & Bankruptcy Law Blog
  • Game Counsel
  • Global Trade Law Blog
  • Government Contracts and Investigations Blog
  • Healthcare Law Blog
  • Hospice Law Blog
  • Insurance Law Blog
  • Intellectual Property Law Blog
  • Labor & Employment Law Blog
  • Latin American Blog
  • Law of the Ledger
  • Lex Arbitri
  • New York Commercial Division Round Up Blog
  • Organizational Integrity Group Blog
  • Real Estate, Land Use & Environmental Law Blog
  • Retail Trend Spotter
  • Sheppard Mullin In The Know
  • Trade Secrets Law Blog
  • U.S. Legal Insights for French Businesses
  • U.S. Legal Insights for Korean Businesses
  • Venture Law Blog

Government Contracts & Investigations Blog

Subscribe to this blog via RSS LinkedIn Twitter Facebook
Privacy PolicyDisclaimer

About The Firm

Sheppard Mullin is a full-service Global 100 firm with more than 1000 attorneys in 15 offices located in the United States, Europe and Asia. Since 1927, industry-leading companies have turned to Sheppard Mullin to handle corporate and technology matters, high-stakes litigation and complex financial transactions. In the U.S., the firm’s clients include more than half of the Fortune 100. For more information, please visit www.sheppardmullin.com.

Copyright © 2022, Sheppard, Mullin, Richter & Hampton LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.

Agree